UA58034U - Method for evaluation of risk of development of complications of course of chronic kidney disease in patients that are treated with program hemodialysis - Google Patents

Method for evaluation of risk of development of complications of course of chronic kidney disease in patients that are treated with program hemodialysis

Info

Publication number
UA58034U
UA58034U UAU201011109U UAU201011109U UA58034U UA 58034 U UA58034 U UA 58034U UA U201011109 U UAU201011109 U UA U201011109U UA U201011109 U UAU201011109 U UA U201011109U UA 58034 U UA58034 U UA 58034U
Authority
UA
Ukraine
Prior art keywords
patients
kidney disease
chronic kidney
complications
evaluation
Prior art date
Application number
UAU201011109U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Ирина Алексеевна Дударь
Леся Викторовна Король
Людмила Ефимовна Мигаль
Юрий Иванович Гончар
Евгения Михайловна Григорьева
Original Assignee
Государственное Учреждение «Институт Нефрологии Академии Медицинских Наук Украины»
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственное Учреждение «Институт Нефрологии Академии Медицинских Наук Украины» filed Critical Государственное Учреждение «Институт Нефрологии Академии Медицинских Наук Украины»
Priority to UAU201011109U priority Critical patent/UA58034U/en
Publication of UA58034U publication Critical patent/UA58034U/en

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Method for evaluation of risk of development of complications of chronic kidney disease in patients that are treated with programmed hemodialysis includes determination of concentration of ceruloplasmin and transferin in blood serum and calculation of ratio of those in patients with chronic kidney disease. On determines concentration of ceruloplasmin and transferin in blood serum with calculation of ratio of those, with comparison of results obtained to index of cellular insufficiency
UAU201011109U 2010-09-16 2010-09-16 Method for evaluation of risk of development of complications of course of chronic kidney disease in patients that are treated with program hemodialysis UA58034U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201011109U UA58034U (en) 2010-09-16 2010-09-16 Method for evaluation of risk of development of complications of course of chronic kidney disease in patients that are treated with program hemodialysis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201011109U UA58034U (en) 2010-09-16 2010-09-16 Method for evaluation of risk of development of complications of course of chronic kidney disease in patients that are treated with program hemodialysis

Publications (1)

Publication Number Publication Date
UA58034U true UA58034U (en) 2011-03-25

Family

ID=50831738

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201011109U UA58034U (en) 2010-09-16 2010-09-16 Method for evaluation of risk of development of complications of course of chronic kidney disease in patients that are treated with program hemodialysis

Country Status (1)

Country Link
UA (1) UA58034U (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2583970C1 (en) * 2015-03-03 2016-05-10 Константин Дмитриевич Клочков Stun shell

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2583970C1 (en) * 2015-03-03 2016-05-10 Константин Дмитриевич Клочков Stun shell

Similar Documents

Publication Publication Date Title
MY165499A (en) Monoclonal antibodies against tissue factor pathway inhibitor (tfpi)
NZ716473A (en) Diagnosis and therapy of cancer involving cancer stem cells
MX2014015615A (en) Use of ferric citrate in the treatment of chronic kidney disease patients.
WO2012135573A3 (en) Systems and methods for varying blood flow to identify autoregulatory ranges in a patient
HK1204537A1 (en) Method for determining glucose concentration in human blood
EP3411689A4 (en) Analyte system and method for determining hemoglobin parameters in whole blood
WO2013071012A3 (en) Personalized strategic cancer treatment
MX361881B (en) Therapy prediction and optimization of serum potassium for renal failure blood therapy, especially home hemodialysis.
NZ602996A (en) Therapy prediction and optimization for renal failure blood therapy, especially home hemodialysis
CA2863106A1 (en) Hbv immunocomplexes for response prediction and therapy monitoring of chronic hbv patients
GB2523211A8 (en) MCT protein inhibitor-related prognostic and therapeutic methods
UA58034U (en) Method for evaluation of risk of development of complications of course of chronic kidney disease in patients that are treated with program hemodialysis
WO2012145399A3 (en) Methods of diagnosing cancer in a patient
RU2015153810A (en) METHOD FOR PREDICTING A THERAPEUTIC EFFECT FOR A PATIENT WITH COLORECTAL CANCER WHICH TK1 PROTEIN EXPRESSION HAS BEEN INCREASED
EA201501095A1 (en) EFFECTIVE TREATMENT OF NSCLC AND A PREDICTIVE CLINICAL MARKER OF SENSITIVE TREATMENT TO TUMOR
UA62757U (en) Method for prediction of adequacy of program hemodialysis in patients with chronic kidney disorder of v stage
MX2014014821A (en) Blood plasma biomarkers for bevacizumab combination therapies for treatment of breast cancer.
UA64465U (en) Method for diagnostics of dysplasia of connective tissue in patients with tuberculosis of respiratory system
WO2010093214A3 (en) Monoclonal antibody recognizing scye1 and use thereof
NZ624444A (en) Blood plasma biomarkers for bevacizumab combination therapies for treatment of breast cancer
WO2014145797A3 (en) Method for treating eclampsia and preeclampsia
UA63210U (en) Method for determination of fetoplacental insufficiency in pregnant with toxic struma
UA65684U (en) method for determination of increased level of body sensitization
UA107451U (en) METHOD OF COMPLEX ASSESSMENT OF ERYTHROCYTIC RESISTANCE IN PATIENTS WITH CHRONIC KIDNEY DISEASE WITH STAGE WITH ANEMIA, TREATED BY NIRCINOSYASINOSIS
UA62777U (en) Method for early diagnosis of severity grade of renal failure of various genesis